Trust Point Inc. Sells 2,626 Shares of Addus HomeCare Corporation (NASDAQ:ADUS)

Trust Point Inc. trimmed its holdings in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 55.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,089 shares of the company's stock after selling 2,626 shares during the quarter. Trust Point Inc.'s holdings in Addus HomeCare were worth $207,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of ADUS. Capital Research Global Investors bought a new stake in shares of Addus HomeCare in the 4th quarter valued at $51,149,000. American Century Companies Inc. boosted its stake in shares of Addus HomeCare by 695.8% in the 4th quarter. American Century Companies Inc. now owns 284,346 shares of the company's stock valued at $35,643,000 after purchasing an additional 248,613 shares during the last quarter. GAMMA Investing LLC boosted its stake in shares of Addus HomeCare by 10,307.8% in the 1st quarter. GAMMA Investing LLC now owns 130,930 shares of the company's stock valued at $12,948,000 after purchasing an additional 129,672 shares during the last quarter. Bank of America Corp DE boosted its stake in shares of Addus HomeCare by 273.6% in the 4th quarter. Bank of America Corp DE now owns 175,070 shares of the company's stock valued at $21,945,000 after purchasing an additional 128,211 shares during the last quarter. Finally, TimesSquare Capital Management LLC boosted its stake in shares of Addus HomeCare by 28.5% in the 4th quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company's stock valued at $44,593,000 after purchasing an additional 78,835 shares during the last quarter. 95.35% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 2,045 shares of the firm's stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total transaction of $235,175.00. Following the transaction, the executive vice president now directly owns 7,796 shares in the company, valued at approximately $896,540. This trade represents a 20.78% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 4.60% of the company's stock.

Addus HomeCare Stock Down 1.2%

ADUS stock traded down $1.37 during midday trading on Friday, reaching $113.79. 195,824 shares of the company's stock traded hands, compared to its average volume of 170,637. Addus HomeCare Corporation has a 52 week low of $88.96 and a 52 week high of $136.72. The company has a market cap of $2.09 billion, a price-to-earnings ratio of 25.69, a P/E/G ratio of 1.61 and a beta of 0.81. The firm's fifty day moving average price is $108.91 and its 200-day moving average price is $111.90. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.20.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its earnings results on Monday, May 5th. The company reported $1.42 EPS for the quarter, topping the consensus estimate of $1.33 by $0.09. Addus HomeCare had a net margin of 6.52% and a return on equity of 9.23%. The company had revenue of $337.71 million during the quarter, compared to the consensus estimate of $341.66 million. During the same period in the previous year, the firm posted $1.21 earnings per share. The firm's revenue for the quarter was up 20.3% on a year-over-year basis. As a group, sell-side analysts forecast that Addus HomeCare Corporation will post 4.59 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have recently commented on ADUS. Macquarie reaffirmed an "outperform" rating and issued a $133.00 price objective on shares of Addus HomeCare in a research note on Tuesday, June 10th. Wall Street Zen cut shares of Addus HomeCare from a "buy" rating to a "hold" rating in a report on Saturday. Stephens reaffirmed an "overweight" rating and issued a $142.00 price target on shares of Addus HomeCare in a research note on Wednesday, March 12th. Finally, JMP Securities restated a "market outperform" rating and issued a $150.00 target price on shares of Addus HomeCare in a research note on Friday. One equities research analyst has rated the stock with a hold rating, six have issued a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of $142.57.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.